Article
TERT promoter mutations in thyroid cancer.
Endocrine-related cancer - 1 Mar 2016
Liu Rengyun, Xing Mingzhao
Abstract excerpt
The 2013 discovery of Telomerase reverse transcriptase (TERT) promoter mutations chr5, 1,295,228 C>T (C228T) and 1,295,250 C>T (C250T) in thyroid cancer represents an important event in the thyroid cancer field and much progress has occurred since then. This article provides a comprehensive review of this exciting new thyroid cancer field. The oncogenic role of TERT promoter mutations involves their creation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
